Intervene with JAKAFI XR
Explore the data through expert perspectives
POLYCYTHEMIA VERA
For treatment of PV in adults who have had an inadequate response to or are intolerant of hydroxyurea
Hana Safah, MD
MPN Expert
MYELOFIBROSIS
For treatment of intermediate- or high-risk MF, including primary MF, post–polycythemia vera MF, and post–essential thrombocythemia MF in adults
Jamie Koprivnikar, MD
MPN Expert
CHRONIC GRAFT-VERSUS-HOST DISEASE
For treatment of cGVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older
Haris Ali, MD
GVHD Expert
ACUTE GRAFT-VERSUS-HOST DISEASE
For treatment of steroid-refractory aGVHD in adult and pediatric patients 12 years and older
Michael Bishop, MD
GVHD Expert
MPN=myeloproliferative neoplasm.
For treatment of intermediate- or high-risk MF, including...
Jamie Koprivnikar, MD
MPN Expert
For treatment of cGVHD after failure of one or two lines of...
Haris Ali, MD
GVHD Expert
For treatment of steroid-refractory aGVHD in adult and...
Michael Bishop, MD
GVHD Expert
MPN=myeloproliferative neoplasm.